Invention Grant
- Patent Title: Oligonucleotide probe inversion process for in situ synthesized probe arrays
-
Application No.: US15305213Application Date: 2015-05-22
-
Publication No.: US10533216B2Publication Date: 2020-01-14
- Inventor: Glenn McGall , Vijay Singh
- Applicant: CENTRILLION TECHNOLOGY HOLDINGS CORPORATION
- Applicant Address: KY Grand Cayman
- Assignee: CENTRILLION TECHNOLOGY HOLDINGS CORPORATION
- Current Assignee: CENTRILLION TECHNOLOGY HOLDINGS CORPORATION
- Current Assignee Address: KY Grand Cayman
- Agency: Wilson Sonsini Goodrich & Rosati, LLP
- International Application: PCT/US2015/032227 WO 20150522
- International Announcement: WO2015/179790 WO 20151126
- Main IPC: C07H21/00
- IPC: C07H21/00 ; C12Q1/6837 ; C12Q1/6834 ; C40B50/18

Abstract:
The present disclosure relates to processes for inverting oligonucleotide probes in an in situ synthesized array. These processes can be used to reverse the orientation of probes with respect to the substrate from 3′-bound to 5′-bound. These processes can also be used to reduce or eliminate the presence of truncated probe sequences from an in situ synthesized array.
Public/Granted literature
- US20170067095A1 OLIGONUCLEOTIDE PROBE INVERSION PROCESS FOR IN SITU SYNTHESIZED PROBE ARRAYS Public/Granted day:2017-03-09
Information query